S

Sunzen Biotech Bhd
KLSE:SUNZEN

Watchlist Manager
Sunzen Biotech Bhd
KLSE:SUNZEN
Watchlist
Price: 0.31 MYR Market Closed
Market Cap: 249.5m MYR
Have any thoughts about
Sunzen Biotech Bhd?
Write Note

Sunzen Biotech Bhd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sunzen Biotech Bhd
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
S
Sunzen Biotech Bhd
KLSE:SUNZEN
Net Income (Common)
myr9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
12%
D
Dswiss Inc
OTC:DQWS
Net Income (Common)
$71.7k
CAGR 3-Years
-13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
E
Eng Kah Corporation Bhd
KLSE:ENGKAH
Net Income (Common)
-myr3.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
K
Karex Bhd
KLSE:KAREX
Net Income (Common)
myr19.6m
CAGR 3-Years
N/A
CAGR 5-Years
118%
CAGR 10-Years
-9%
B
Bioalpha Holdings Bhd
KLSE:BIOHLDG
Net Income (Common)
-myr36.1m
CAGR 3-Years
-15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Sunzen Biotech Bhd
Glance View

Market Cap
249.5m MYR
Industry
Consumer products

Sunzen Biotech Bhd.is an investment holding company, which engages in biotechnology research and development, and the manufacture and marketing of animal feed supplement products. The company is headquartered in Shah Alam, Selangor. The company went IPO on 2008-10-08. Its segments include Manufacturing and trading of animal health products (AH), Trading of crude palm oil products (CPO), Traditional Chinese medicines, herbal foods and beverages, bird's nest (TCM) and Loan financing. The company specializes in animal health and nutrition, manufactures and markets a range of related products for both livestock and companion animals. The company is also involved in the palm oil trading business, which entails the trading of crude palm oil and its derivative products. Its product categories include feed additive, oral pump, functional red palm oil, injectables, water soluble, detergent and disinfection and premix. Its animal health products are offered to domestic and overseas markets in countries, such as China, Korea and the Middle East.

SUNZEN Intrinsic Value
0.22 MYR
Overvaluation 28%
Intrinsic Value
Price
S

See Also

What is Sunzen Biotech Bhd's Net Income (Common)?
Net Income (Common)
9m MYR

Based on the financial report for Jun 30, 2024, Sunzen Biotech Bhd's Net Income (Common) amounts to 9m MYR.

What is Sunzen Biotech Bhd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
12%

Over the last year, the Net Income (Common) growth was 110%.

Back to Top